Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Alaska Governor Mike Dunleavy arrived in South Korea on Monday to hold a series of one-on-one meetings with top executives from Korean energy and st...
Hanmi Semiconductor Co. on Thursday announced a plan to retire 130.0 billion won ($90 million) worth of treasury shares in May, marking its largest-...
Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, held a ground-breaking ceremony for its seventh plant of...
Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
South Korea's Hanmi Pharmaceutical Co. said on Friday that Beijing Hanmi Pharm, its subsidiary in China, held the groundbreaking ceremony for a proj...
La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...
South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...
It began in 1982 as a small community bank for Korean immigrants in Los Angeles, California. Today, Hanmi Bank, under Nasdaq-listed Hanmi Financial ...
A number of junior bankers at the Korean offices of major global investment banks such as Morgan Stanely and J.P.Morgan have resigned since July wit...
South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...
South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder h...
Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, has revised upwards its annual sales target for this yea...
Global chip packaging equipment manufacturers are enjoying surging demand and skyrocketing share prices thanks to the rapid growth of the artificial...
South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has received an order from SK Hynix Inc. for its dual TC bon...
South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...
South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...
The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its ...
Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who oppo...
The merger of South Korea’s pharmaceutical holding firm Hanmi Science Co. and chemicals giant OCI Holdings Co. is likely to gain momentum as N...
South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has secured a 21.5 billion won ($16.1 million) supply deal f...
South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group&rsquo...
Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investme...
Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...
Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...